Literature DB >> 10905449

Use of the nine-step inflation/deflation test as a predictor of middle ear barotrauma in sports scuba divers.

C Uzun1, M K Adali, A Tas, M Koten, A R Karasalihoglu, M Devren.   

Abstract

Middle ear (ME) barotrauma, the most common disorder encountered in diving, results from inadequate pressure equilibration between the ME and the ambient environment. Eustachian tube function plays a key role in the pathogenesis of barotrauma. This study was designed to investigate the predictive value and efficiency of tympanometric tests of Eustachian tube function (Valsalva test, Toynbee test and nine-step inflation/deflation test) in predicting ME barotrauma in 44 ears of 22 sports scuba divers who had normal audiometry, tympanometry and otorhinolaryngological examination without previous history of ear disease. The divers were counselled to refer to the investigators if any symptoms occurred during and/or after diving. All symptomatic ears were examined within 24 hours of diving by one investigator who was unaware of the pre-symptomatic test results. Decision matrix analysis was applied to the results of Eustachian tube function tests for predicting ears with barotrauma. Values were also evaluated for a battery of tests by 'Lax' (positive on A, B or C) and 'Strict' (positive on A, B and C) criteria. The nine-step test was found to be the most efficient (93%) test with highest predictive values (PPV 83%; NPV 95%), whereas the Valsalva and Toynbee tests were unreliable in predicting barotrauma, whereas the Valsalva and Toynbee tests were unreliable in predicting barotrauma (PPV of the Valsalva and Toynbee tests were 0% and 25% respectively). Combining the nine-step and Toynbee tests into a two-test battery in a strict approach increased the PPV (100%). It appears that the nine-step inflation/deflation test is a reliable method of predicting ME barotrauma sufferers, especially when applied with the Toynbee test. The nine-step test may have value in the evaluation of Eustachian tube function of sports scuba diving candidates after routine otorhinolaryngological, audiological and tympanometric evaluation.

Entities:  

Mesh:

Year:  2000        PMID: 10905449     DOI: 10.3109/03005364000000125

Source DB:  PubMed          Journal:  Br J Audiol        ISSN: 0300-5364


  7 in total

1.  Effects of non-invasive ventilation on middle ear function in healthy volunteers.

Authors:  Franco Cavaliere; Simonetta Masieri; Giorgio Conti; Massimo Antonelli; Mariano Alberto Pennisi; Roberto Filipo; Rodolfo Proietti
Journal:  Intensive Care Med       Date:  2003-02-13       Impact factor: 17.440

2.  Auditory complaints in scuba divers: an overview.

Authors:  Rachel A Evens; Barry Bardsley; Vinaya K C Manchaiah
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-10-08

3.  Eustachian tube balloon dilation in treatment of equalization problems of freediving spearfishermen.

Authors:  Antonio Am Giunta; Luca Liberati; Cristina Pellegrino; Giampietro Ricci; Santino Rizzo
Journal:  Diving Hyperb Med       Date:  2019-03-31       Impact factor: 0.887

4.  Middle ear barotrauma in diving.

Authors:  Oskari H Lindfors; Anne K Räisänen-Sokolowski; Jari Suvilehto; Saku T Sinkkonen
Journal:  Diving Hyperb Med       Date:  2021-03-31       Impact factor: 0.887

5.  Update on middle ear barotrauma after hyperbaric oxygen therapy-insights on pathophysiology.

Authors:  Marco Antônio Rios Lima; Luciano Farage; Maria Cristina Lancia Cury; Fayez Bahamad
Journal:  Int Arch Otorhinolaryngol       Date:  2014-02-10

6.  Revisiting the Diagnostic Performance of the Modified Nine-Step Test for Obstructive and Patulous Eustachian Tube Dysfunction.

Authors:  Seong Hoon Bae; Seojin Moon; Mincheol Jeong; In Seok Moon
Journal:  Diagnostics (Basel)       Date:  2022-03-17

Review 7.  Inner Ear Disorders in SCUBA Divers: A Review.

Authors:  Alfonso Scarpa; Massimo Ralli; Pietro De Luca; Federico Maria Gioacchini; Matteo Cavaliere; Massimo Re; Ettore Cassandro; Claudia Cassandro
Journal:  J Int Adv Otol       Date:  2021-05       Impact factor: 1.316

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.